TR201819137T4 - Therapeutic nuclease compositions and methods. - Google Patents

Therapeutic nuclease compositions and methods. Download PDF

Info

Publication number
TR201819137T4
TR201819137T4 TR2018/19137T TR201819137T TR201819137T4 TR 201819137 T4 TR201819137 T4 TR 201819137T4 TR 2018/19137 T TR2018/19137 T TR 2018/19137T TR 201819137 T TR201819137 T TR 201819137T TR 201819137 T4 TR201819137 T4 TR 201819137T4
Authority
TR
Turkey
Prior art keywords
methods
therapeutic nuclease
nuclease compositions
compositions
therapeutic
Prior art date
Application number
TR2018/19137T
Other languages
Turkish (tr)
Inventor
A Ledbetter Jeffrey
Hayden-Ledbetter Martha
Elkon Keith
Sun Xizhang
Original Assignee
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Washington filed Critical Univ Washington
Publication of TR201819137T4 publication Critical patent/TR201819137T4/en

Links

Abstract

Bir memelideki immün ilişkili bir hastalığın veya bozukluğun tedavi edilmesine yönelik melez nükleaz molekülleri ve yöntemler ve bir memelide immün ilişkili bir hastalığın tedavi edilmesine yönelik farmasötik bir bileşimdir.Hybrid nuclease molecules and methods for treating an immune-related disease or disorder in a mammal and a pharmaceutical composition for treating an immune-related disease in a mammal.

TR2018/19137T 2010-08-04 2010-11-02 Therapeutic nuclease compositions and methods. TR201819137T4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37075210P 2010-08-04 2010-08-04
US25745810P 2010-08-04 2010-08-04

Publications (1)

Publication Number Publication Date
TR201819137T4 true TR201819137T4 (en) 2019-01-21

Family

ID=67928550

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2018/19137T TR201819137T4 (en) 2010-08-04 2010-11-02 Therapeutic nuclease compositions and methods.

Country Status (1)

Country Link
TR (1) TR201819137T4 (en)

Similar Documents

Publication Publication Date Title
CY1123684T1 (en) THERAPEUTIC NUCLEASE COMPOSITIONS AND METHODS
MX2021015735A (en) Therapeutic nuclease compositions and methods.
HK1209036A1 (en) Methods and compositions for improving gut microbiota population
HK1203566A1 (en) Methods and compositions for treating huntingtons disease
SG10201500048SA (en) Compositions and methods for treating glioblastoma gbm
EA201390804A1 (en) DOSAGE FORM LACOSAMIDE FOR ADMISSION ONCE IN DAY
EP2627305A4 (en) Compositions and methods for treating keratin based fibers
MX347164B (en) Anti il-36r antibodies.
EA201000146A1 (en) MILARD BINDING ON THE BASIS OF HYDROXYMUNICARBONIC ACID
TR201904980T4 (en) Pharmaceutical combinations comprising a B-Raf inhibitor, an EGFR inhibitor and optionally a PI3K-alpha inhibitor.
HK1201771A1 (en) Compositions and methods for treating alzheimers disease
PL2917231T3 (en) Lipopeptides for use in treating liver diseases and cardiovascular diseases
HRP20180687T1 (en) Compositions and methods for treating celiac sprue disease
EP2709614A4 (en) Pharmaceutical compositions and methods for treating cancer
ZA201404248B (en) Compositions and methods for diagnosing and treating hyperthyroidism in compositions animals
SG11201400976WA (en) Methods and pharmaceutical compositions for treating cancer
EP2693877A4 (en) Methods and compositions for treating raynaud's disease
TR201819137T4 (en) Therapeutic nuclease compositions and methods.
BR112014032456A2 (en) in vitro methods, pharmaceutical composition, method kit and method for improving the treatment effect
TN2013000433A1 (en) Therapeutic nuclease compositions and methods
EP2718427A4 (en) Compositions and methods for glioblastoma treatment
IL238389A (en) Phosphate based oligomers and conjugates for delivering therapeutic agents into living cells and cells nuclei
BR112015003815A2 (en) methods and compositions for treating a genetic condition
TN2014000207A1 (en) Anti il-36r antibodies
BR112013030381A2 (en) reagents and methods for treating dental disease